About Us
We specialize in early detection of COPD.
Currently, there are over 16.4 million people in the U.S. who suffer from COPD. Of those, 24% of them will be readmitted to the hospitals due to increased symptoms or severity. At LASARRUS we are creating device-enabled solutions for remote monitoring of Chronic Obstructive Pulmonary Disease (COPD) that is reliable, accurate and easy to use.
.png)
WearME System
Timeline
2018
Intel Contest Winner
Wearable design contest winner.
2018- Present
3 SBIR Grants
Remote Monitoring of Patients with COPD: A Longitudinal Study
2020- Present
4 Patents Awarded
4 pending patents and 4+ publications
2024- Present
Multiple Pilot Agreements
John Hopkins, Apria, Tower Health Provider and Tidal Health.
2025- Present
$3.25M raised to date
$2.78M SBIR, $428K Notes, $50K Black Ambition
2026
FDA Clearance
Product Launch!
Follow our journey — see the key milestones leading to launch!
Our Founders
LASARRUS is founded by four brothers with over 50 years of cumulative professional experience, with each bringing a unique value to the success of the company.
Our Team
Our Advisors
Financial Strategy and Operations Team
AS FEATURED ON
We Take Pride In Being The 2018 Intel Design Contest Winners
Intel FPGA Innovation Day
"A master class in FPGA-inspired technology innovation."
_svg.png){kind=logo}
The Possibilities Are Endless
Partners
